Do you have the same question? Follow this Question
Nov 14, 2024 - 01:38 PM
We’ve provided several answers to questions related to Rexulti (Brexpiprazole) , see some other helpful Q&A related to this product.
Question: What is the KEGG ID for this medication?
Answer: The KEGG ID for this medication is D10309. KEGG (Kyoto Encyclopedia of Genes and Genomes) offers insights into drug interactions at the molecular level, aiding in research and personalized medicine approaches.
Question: What is the max dose for pediatric patients with schizophrenia?
Answer: The max dose for pediatric patients with schizophrenia is 4 mg/day. This maximum ensures that the treatment remains within safe parameters while effectively managing symptoms.
Question: What is the starting dose for adults with schizophrenia?
Answer: The starting dose for adults with schizophrenia is 1 mg/day. Starting at this dose helps manage symptoms like delusions and hallucinations while minimizing initial side effects.
Question: What is the starting dose for adults with major depressive disorder?
Answer: The starting dose for adults with major depressive disorder is 0.5 mg/day or 1 mg/day. Starting at a low dose helps assess tolerance and minimize side effects while adjusting to the medication.
Question: What is the bioavailability of the medication?
Answer: The bioavailability of the medication is 95%. This high bioavailability ensures that a significant amount of the drug reaches systemic circulation, making it effective in achieving the desired therapeutic effects.
